{"hands_on_practices": [{"introduction": "Before we can model the effects of a Damage-Associated Molecular Pattern (DAMP), we must be certain that our molecule of interest is a bona fide endogenous danger signal. This is a formidable challenge in immunology, as minute contamination with highly potent Pathogen-Associated Molecular Patterns (PAMPs) like endotoxin can easily lead to false conclusions. This practice problem guides you through the critical thought process of experimental validation, challenging you to design a series of tests that would most convincingly establish a candidate protein as a DAMP acting through a specific receptor [@problem_id:2879779].", "problem": "An investigator isolates a human nuclear protein candidate, denoted $\\mathcal{D}$, that is released from necrotic cells and is hypothesized to function as a Damage-Associated Molecular Pattern (DAMP). The goal is to validate $\\mathcal{D}$ as a bona fide DAMP by applying criteria that exclude hidden Pathogen-Associated Molecular Pattern (PAMP) contaminants and that demonstrate dependence on a specific Pattern Recognition Receptor (PRR). The investigator can use in vitro stimulation of primary myeloid cells and in vivo sterile injury models, together with biochemical purification, enzymatic treatments, pharmacologic inhibitors, and genetic perturbations. Which of the following experimental criteria, taken together, would most convincingly establish that $\\mathcal{D}$ is an endogenous DAMP rather than an effect of PAMP contamination, and that its activity is receptor-dependent? Select ALL that apply.\n\nNote: All acronyms are defined at first use. DAMP stands for Damage-Associated Molecular Pattern, PAMP stands for Pathogen-Associated Molecular Pattern, and PRR stands for Pattern Recognition Receptor. Limulus Amebocyte Lysate (LAL) is an assay for endotoxin. Endotoxin Units (EU) are the readout units of LAL. Deoxyribonuclease (DNase) and Ribonuclease (RNase) are nucleases. Receptor for Advanced Glycation Endproducts (RAGE) is a candidate DAMP receptor. Toll-like Receptor 4 (TLR4) and Toll-like Receptor 2 (TLR2) are canonical PAMP sensors. Human Embryonic Kidney 293 (HEK293) cells are used for reporter assays. Cyclic GMP-AMP synthase (cGAS) and Stimulator of Interferon Genes (STING) mediate cytosolic DNA sensing.\n\nA. Purified $\\mathcal{D}$ induces a dose-dependent cytokine response in primary mouse macrophages; activity is abolished by proteinase K and heat denaturation, but unaffected by DNase and RNase. Endotoxin is below detection by both LAL and a recombinant Factor C assay ($ 0.01$ EU per $\\mu$g protein), and activity is unaffected by polymyxin B.\n\nB. The same cytokine response to $\\mathcal{D}$ occurs in $Tlr4^{-/-}$ and $Tlr2^{-/-}$ macrophages, but is lost in $Rage^{-/-}$ macrophages and restored by re-expression of RAGE; a neutralizing anti-RAGE antibody blocks the response.\n\nC. Germ-free mice fail to mount an inflammatory response to injected $\\mathcal{D}$, showing dependence on the microbiota and thereby excluding a DAMP mechanism.\n\nD. Inclusion of broad-spectrum antibiotics during in vitro stimulation abolishes PAMP contaminants; persistence of activity under antibiotics is sufficient to conclude DAMP function.\n\nE. In a sterile liver ischemia-reperfusion injury model, extracellular $\\mathcal{D}$ in plasma rises within $1$ hour and correlates with neutrophil infiltration; administration of a blocking antibody to the hypothesized receptor reduces inflammatory cytokines by $ 80\\%$ without altering extracellular $\\mathcal{D}$ levels.\n\nF. $\\mathcal{D}$ triggers reporter activation in a HEK293 cell line overexpressing TLR4, and polymyxin B blocks the response; therefore, TLR4 is concluded to be the DAMP receptor.\n\nG. Ultracentrifugation and Triton X-$100$ treatment do not reduce $\\mathcal{D}$ activity, excluding lipoprotein or lipopeptide contaminants that stimulate TLR2; $Tlr2^{-/-}$ cells respond normally to $\\mathcal{D}$.\n\nH. Activity does not require transfection reagents, and $cGas^{-/-}$ and $Sting^{-/-}$ macrophages respond normally to extracellular $\\mathcal{D}$ addition, ruling out cytosolic nucleic acid sensing as the mechanism of activation.", "solution": "The validity of the problem statement must first be assessed.\n\n### Step 1: Extract Givens\n- A human nuclear protein candidate is denoted as $\\mathcal{D}$.\n- $\\mathcal{D}$ is released from necrotic cells and hypothesized to be a Damage-Associated Molecular Pattern (DAMP).\n- The goal is to validate $\\mathcal{D}$ as a DAMP by excluding Pathogen-Associated Molecular Pattern (PAMP) contaminants and demonstrating dependence on a specific Pattern Recognition Receptor (PRR).\n- Available methods include: *in vitro* stimulation of primary myeloid cells, *in vivo* sterile injury models, biochemical purification, enzymatic treatments (Deoxyribonuclease (DNase), Ribonuclease (RNase)), pharmacologic inhibitors, and genetic perturbations.\n- Definitions provided: Limulus Amebocyte Lysate (LAL), Endotoxin Units (EU), Receptor for Advanced Glycation Endproducts (RAGE), Toll-like Receptor 4 (TLR4), Toll-like Receptor 2 (TLR2), Human Embryonic Kidney 293 (HEK293) cells, Cyclic GMP-AMP synthase (cGAS), Stimulator of Interferon Genes (STING).\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, posing a classic and critical question in immunology: how to distinguish a true endogenous danger signal (DAMP) from confounding microbial contaminants (PAMPs). The concepts, molecules (e.g., TLR4, RAGE), and experimental techniques (e.g., knockout cells, enzymatic degradation, endotoxin assays) are all standard and fundamental to the field. The problem is well-posed, objective, and self-contained, providing sufficient information to evaluate the proposed experimental criteria based on established scientific principles. The problem does not violate any criteria for validity.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. A solution will be derived by analyzing each option.\n\n---\n\nTo convincingly establish that $\\mathcal{D}$ is a bona fide DAMP acting through a specific receptor, the experimental evidence must rigorously satisfy two main criteria:\n$1$. The biological activity must be intrinsic to the protein $\\mathcal{D}$ itself, and not a result of contamination with PAMPs (e.g., endotoxin, bacterial lipoproteins, microbial nucleic acids) or other DAMPs (e.g., host DNA).\n$2$. The activity must be mediated by a specific PRR, demonstrated through genetic and pharmacological loss-of-function and gain-of-function experiments.\n$3$. The DAMP-receptor axis must be shown to be relevant in a physiological *in vivo* context of sterile tissue injury.\n\nEach option will now be evaluated against these strict criteria.\n\n**Option A:** Purified $\\mathcal{D}$ induces a dose-dependent cytokine response in primary mouse macrophages; activity is abolished by proteinase K and heat denaturation, but unaffected by DNase and RNase. Endotoxin is below detection by both LAL and a recombinant Factor C assay ($ 0.01$ EU per $\\mu$g protein), and activity is unaffected by polymyxin B.\n*   **Analysis**: This option provides a strong foundation for criterion $1$. The dose-dependent response is expected. Sensitivity to proteinase K and heat confirms the active agent is a protein with a specific tertiary structure. Insensitivity to DNase and RNase rules out contaminating nucleic acids as the active moiety. Crucially, it addresses the most common contaminant, endotoxin (LPS), with two independent quantitative assays showing negligible levels, and a functional assay with polymyxin B confirming that this trace amount is not responsible for the activity. This is a well-designed set of initial validation experiments.\n*   **Verdict**: **Correct**. This set of controls is essential to establish the biochemical nature of the active ligand.\n\n**Option B:** The same cytokine response to $\\mathcal{D}$ occurs in $Tlr4^{-/-}$ and $Tlr2^{-/-}$ macrophages, but is lost in $Rage^{-/-}$ macrophages and restored by re-expression of RAGE; a neutralizing anti-RAGE antibody blocks the response.\n*   **Analysis**: This option provides exceptionally strong evidence for criterion $2$, and further strengthens criterion $1$. The normal response in $Tlr4^{-/-}$ and $Tlr2^{-/-}$ macrophages provides the genetic \"gold standard\" for ruling out contamination with ligands for TLR4 (LPS) and TLR2 (lipoproteins). The loss of response in $Rage^{-/-}$ macrophages is definitive genetic loss-of-function evidence for RAGE being the receptor. This is powerfully confirmed by the gain-of-function \"rescue\" experiment (re-expression of RAGE) and corroborated by pharmacological blockade with an anti-RAGE antibody. This combination of genetic and pharmacological evidence is the highest standard for receptor identification.\n*   **Verdict**: **Correct**. These experiments definitively identify the receptor and provide powerful orthogonal evidence against PAMP contamination.\n\n**Option C:** Germ-free mice fail to mount an inflammatory response to injected $\\mathcal{D}$, showing dependence on the microbiota and thereby excluding a DAMP mechanism.\n*   **Analysis**: This option describes a hypothetical result and draws a dubious conclusion. The failure of germ-free mice to respond does not automatically \"exclude a DAMP mechanism\". The microbiota can be required to prime the immune system, and its absence could render the system hyporesponsive to a variety of stimuli, including DAMPs. This finding would necessitate further investigation; it is not a criterion that establishes or refutes DAMP function on its own, and the conclusion presented is a logical leap.\n*   **Verdict**: **Incorrect**.\n\n**Option D:** Inclusion of broad-spectrum antibiotics during *in vitro* stimulation abolishes PAMP contaminants; persistence of activity under antibiotics is sufficient to conclude DAMP function.\n*   **Analysis**: This control is fundamentally flawed. Antibiotics kill live bacteria but do not eliminate or inactivate pre-existing, stable PAMPs like endotoxin or lipoproteins present in the purified $\\mathcal{D}$ preparation. Therefore, persistence of activity in the presence of antibiotics is not \"sufficient to conclude DAMP function\". This is a weak, easily confounded experiment that leads to false-positive conclusions.\n*   **Verdict**: **Incorrect**.\n\n**Option E:** In a sterile liver ischemia-reperfusion injury model, extracellular $\\mathcal{D}$ in plasma rises within $1$ hour and correlates with neutrophil infiltration; administration of a blocking antibody to the hypothesized receptor reduces inflammatory cytokines by $ 80\\%$ without altering extracellular $\\mathcal{D}$ levels.\n*   **Analysis**: This option provides the essential *in vivo* validation (criterion $3$). It demonstrates that the candidate DAMP, $\\mathcal{D}$, is endogenously released during a relevant sterile injury process and that its levels correlate with the inflammatory pathology. Most importantly, it shows that blocking the identified receptor (e.g., RAGE from option B) significantly ameliorates the inflammation *in vivo*. The control showing that the antibody does not affect $\\mathcal{D}$ levels confirms that the effect is due to signal blockade. This connects the molecular mechanism to a physiological or pathological outcome.\n*   **Verdict**: **Correct**. This experiment is critical for demonstrating physiological relevance.\n\n**Option F:** $\\mathcal{D}$ triggers reporter activation in a HEK293 cell line overexpressing TLR4, and polymyxin B blocks the response; therefore, TLR4 is concluded to be the DAMP receptor.\n*   **Analysis**: The experimental result described here is the classic signature of endotoxin (LPS) contamination. HEK293 cells are reporter cells that respond to TLR4 agonists only when TLR4 (and its co-receptors) are overexpressed. The fact that polymyxin B, an LPS-specific antagonist, blocks this signal is definitive proof. The conclusion drawn, that \"TLR4 is the DAMP receptor,\" is precisely the opposite of the correct interpretation. This result would invalidate the hypothesis that $\\mathcal{D}$ is the active molecule and instead prove that the preparation is contaminated.\n*   **Verdict**: **Incorrect**.\n\n**Option G:** Ultracentrifugation and Triton X-$100$ treatment do not reduce $\\mathcal{D}$ activity, excluding lipoprotein or lipopeptide contaminants that stimulate TLR2; $Tlr2^{-/-}$ cells respond normally to $\\mathcal{D}$.\n*   **Analysis**: This option provides rigorous controls against a second major class of PAMP contaminants: bacterial lipoproteins that activate TLR2. It combines a biochemical approach (ultracentrifugation and detergent treatment to remove/disrupt lipidated molecules) with a genetic gold-standard control (normal response in $Tlr2^{-/-}$ cells). This is a crucial step in fulfilling criterion $1$. This complements the evidence in option B, which also uses $Tlr2^{-/-}$ cells.\n*   **Verdict**: **Correct**. This is a necessary and robust control to exclude lipoprotein contamination.\n\n**Option H:** Activity does not require transfection reagents, and $cGas^{-/-}$ and $Sting^{-/-}$ macrophages respond normally to extracellular $\\mathcal{D}$ addition, ruling out cytosolic nucleic acid sensing as the mechanism of activation.\n*   **Analysis**: This option addresses the possibility of contamination with DNA, which can act as a DAMP (mitochondrial DNA) or PAMP (bacterial DNA). Since $\\mathcal{D}$ is a nuclear protein, co-purification with DNA is highly plausible. The cGAS-STING pathway is the primary sensor for cytosolic DNA. Showing that activity does not require transfection (i.e., forced entry into the cytosol) and, more definitively, that it is intact in $cGas^{-/-}$ and $Sting^{-/-}$ cells, rigorously rules out this major alternative pathway.\n*   **Verdict**: **Correct**. This is a critical control given the nuclear origin of the candidate protein $\\mathcal{D}$.\n\n**Conclusion:**\nA \"convincing\" case requires a multi-pronged approach that thoroughly establishes the biochemical nature of the ligand, rigorously excludes all plausible contaminants, definitively identifies the receptor, and demonstrates physiological relevance *in vivo*. Options A, B, E, G, and H collectively achieve this high standard.", "answer": "$$\\boxed{ABEGH}$$", "id": "2879779"}, {"introduction": "Once a DAMP and its receptor are identified, the next step is to understand their interaction quantitatively, especially in the complex milieu of an inflamed tissue. Immune receptors are often exposed to a mixture of PAMPs and DAMPs competing for the same binding site. This exercise applies the fundamental principles of competitive binding kinetics to determine the precise concentration of a PAMP required to trigger a signal in the presence of a competing DAMP, illustrating how receptor occupancy dictates cellular activation thresholds [@problem_id:2879814].", "problem": "A monovalent Pattern Recognition Receptor (PRR) on a macrophage recognizes two mutually exclusive ligands at the same binding site: a Pathogen-Associated Molecular Pattern (PAMP) ligand, denoted by concentration $[P]$, and a Damage-Associated Molecular Pattern (DAMP) ligand, denoted by concentration $[D]$. The system is at thermodynamic equilibrium, ligands are in large molar excess over the receptor such that free ligand concentrations equal their total concentrations, and binding events are independent without cooperativity. The equilibrium dissociation constants are $K_{d,P} = 10\\,\\text{nM}$ for the PAMP and $K_{d,D} = 200\\,\\text{nM}$ for the DAMP. In an inflamed tissue microenvironment, the DAMP is present at a free concentration of $[D] = 100\\,\\text{nM}$.\n\nA downstream nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\\kappa B) signaling module is triggered only if the fractional occupancy of the PRR by the PAMP (not merely by any ligand) reaches at least a threshold $\\tau = 0.60$. Using only fundamental definitions of the equilibrium dissociation constant and mass action at equilibrium, and starting from first principles, determine the minimal free concentration of the PAMP, $[P]_{\\min}$, required to meet the occupancy threshold in the presence of the competing DAMP.\n\nRound your final result to three significant figures and express it in $\\text{nM}$. After computing the minimal concentration, briefly explain the implication of the competing DAMP for the signaling threshold in terms of how $[P]_{\\min}$ scales with $[D]$, $K_{d,D}$, and the threshold $\\tau$.", "solution": "We begin from the law of mass action and the definition of the equilibrium dissociation constant. Let $[R]$ denote the free receptor concentration, $[RP]$ the PAMP-bound receptor concentration, and $[RD]$ the DAMP-bound receptor concentration. For monovalent binding at a single site with mutually exclusive occupancy, the dissociation constants are defined by\n$$\nK_{d,P} = \\frac{[R][P]}{[RP]}, \\qquad K_{d,D} = \\frac{[R][D]}{[RD]}.\n$$\nRearranging gives the bound-to-free ratios\n$$\n\\frac{[RP]}{[R]} = \\frac{[P]}{K_{d,P}}, \\qquad \\frac{[RD]}{[R]} = \\frac{[D]}{K_{d,D}}.\n$$\nThe total receptor concentration is the sum of the three states:\n$$\n[R]_{\\text{tot}} = [R] + [RP] + [RD] = [R]\\!\\left(1 + \\frac{[P]}{K_{d,P}} + \\frac{[D]}{K_{d,D}}\\right).\n$$\nThe fractional occupancy by the PAMP is the fraction of receptors in the $[RP]$ state:\n$$\nf_{P} \\equiv \\frac{[RP]}{[R]_{\\text{tot}}} = \\frac{\\dfrac{[P]}{K_{d,P}}}{1 + \\dfrac{[P]}{K_{d,P}} + \\dfrac{[D]}{K_{d,D}}}.\n$$\nLet $\\tau$ be the threshold occupancy required for signaling. We seek the minimal $[P]$ such that $f_{P} \\ge \\tau$. Monotonicity in $[P]$ allows us to solve the equality $f_{P} = \\tau$ for the minimal concentration. Set $x \\equiv [P]$ and define $\\beta \\equiv \\dfrac{[D]}{K_{d,D}}$. Then\n$$\n\\tau = \\frac{\\dfrac{x}{K_{d,P}}}{1 + \\dfrac{x}{K_{d,P}} + \\beta}.\n$$\nMultiply numerator and denominator to solve for $x$:\n$$\n\\tau\\!\\left(1 + \\frac{x}{K_{d,P}} + \\beta\\right) = \\frac{x}{K_{d,P}} \\quad \\Longrightarrow \\quad \\tau + \\tau\\beta + \\tau\\frac{x}{K_{d,P}} = \\frac{x}{K_{d,P}}.\n$$\nRearrange the $x$-terms:\n$$\n\\left(1 - \\tau\\right)\\frac{x}{K_{d,P}} = \\tau\\left(1 + \\beta\\right),\n$$\nso the minimal concentration that achieves the threshold is\n$$\nx_{\\min} = [P]_{\\min} = \\frac{\\tau}{1 - \\tau}\\,K_{d,P}\\left(1 + \\beta\\right) = \\frac{\\tau}{1 - \\tau}\\,K_{d,P}\\left(1 + \\frac{[D]}{K_{d,D}}\\right).\n$$\nNow substitute the given parameter values $K_{d,P} = 10\\,\\text{nM}$, $K_{d,D} = 200\\,\\text{nM}$, $[D] = 100\\,\\text{nM}$, and $\\tau = 0.60$:\n$$\n\\beta = \\frac{[D]}{K_{d,D}} = \\frac{100\\,\\text{nM}}{200\\,\\text{nM}} = 0.5, \\qquad \\frac{\\tau}{1-\\tau} = \\frac{0.60}{0.40} = 1.5,\n$$\n$$\n[P]_{\\min} = \\left(1.5\\right)\\left(10\\,\\text{nM}\\right)\\left(1 + 0.5\\right) = 1.5 \\times 10\\,\\text{nM} \\times 1.5 = 22.5\\,\\text{nM}.\n$$\nRounded to three significant figures and expressed in $\\text{nM}$, the minimal PAMP concentration is $22.5\\,\\text{nM}$.\n\nImplications for downstream signaling thresholds: The expression\n$$\n[P]_{\\min} = \\frac{\\tau}{1 - \\tau}\\,K_{d,P}\\left(1 + \\frac{[D]}{K_{d,D}}\\right)\n$$\nshows that the presence of a competing DAMP raises the PAMP requirement by the multiplicative factor $\\left(1 + \\dfrac{[D]}{K_{d,D}}\\right)$. Relative to the no-competition case, where $[P]_{\\min}^{(0)} = \\dfrac{\\tau}{1-\\tau}K_{d,P}$, the DAMP increases the threshold to $[P]_{\\min} = [P]_{\\min}^{(0)}\\left(1 + \\dfrac{[D]}{K_{d,D}}\\right)$. Thus, higher $[D]$ or weaker DAMP affinity (larger $K_{d,D}$ lowering $\\dfrac{[D]}{K_{d,D}}$) respectively increases or decreases the PAMP concentration needed to trigger NF-\\kappa B, and higher $\\tau$ imposes a supra-linear increase via the factor $\\dfrac{\\tau}{1-\\tau}$.", "answer": "$$\\boxed{22.5}$$", "id": "2879814"}, {"introduction": "Signaling pathways are not simple on/off switches but complex, dynamic systems that process information over time to produce a specific cellular output. This advanced practice introduces the power of computational systems biology to model and predict the behavior of an entire signaling cascade. By translating the STING pathway into a system of ordinary differential equations (ODEs), you will gain hands-on experience in simulating how a cell integrates a danger signal to mount a precise transcriptional response like the production of IFN-β [@problem_id:2879710].", "problem": "You are to construct a mechanistic ordinary differential equation (ODE) model that captures the phosphorylation dynamics of Interferon Regulatory Factor 3 (IRF3) downstream of Stimulator of Interferon Genes (STING) in response to cytosolic nucleic acids acting as Pathogen-Associated Molecular Patterns (PAMPs) or Damage-Associated Molecular Patterns (DAMPs). The goal is to predict the steady-state concentration of Interferon Beta (IFN-β) protein. The model must be derived from first principles of receptor-ligand binding kinetics, enzyme catalysis, and the Central Dogma (DNA to RNA to protein), without using any shortcut formulas.\n\nBase your derivation on the following well-tested facts and core definitions:\n- The Law of Mass Action for reversible binding between a ligand and a receptor.\n- Michaelis–Menten kinetics for an enzyme-catalyzed covalent modification.\n- First-order decay for molecular degradation processes.\n- The Central Dogma of molecular biology (transcription and translation).\n\nBiological context to be mapped into a mathematical model:\n- Cytosolic DNA (a PAMP or DAMP) leads to cyclic GMP-AMP synthase (cGAS) activation and generation of cyclic GMP-AMP that activates STING. For modeling purposes, treat the upstream cytosolic DNA signal as a constant effective ligand concentration for STING activation, denoted by $L$ (in nM).\n- Activated STING recruits and activates Tank-binding kinase $1$ (TBK1), which phosphorylates IRF3. Phosphorylated IRF3 drives interferon beta gene (IFNB1) transcription.\n- Interferon Beta (IFN-β) is produced via translation of IFNB1 messenger RNA (mRNA) and is degraded over time.\n\nDefine the following state variables, all as concentrations in nM and functions of time $t$ in hours:\n- $x_1(t) = \\text{STING}^\\ast$, the concentration of active STING.\n- $x_2(t) = \\text{TBK1}^\\ast$, the concentration of active TBK1.\n- $x_3(t) = \\text{IRF3-P}$, the concentration of phosphorylated IRF3.\n- $x_4(t) = \\text{IFNB1 mRNA}$, the concentration of IFNB1 mRNA.\n- $x_5(t) = \\text{IFN-}\\beta$, the concentration of IFN-β protein.\n\nUse the following conserved totals:\n- $S_{\\text{tot}}$ (total STING), $T_{\\text{tot}}$ (total TBK1), and $I_{\\text{tot}}$ (total IRF3), all in nM, with $S_{\\text{tot}}, T_{\\text{tot}}, I_{\\text{tot}}$ constant in time.\n- The free species are $S_{\\text{free}} = S_{\\text{tot}} - x_1$, $T_{\\text{free}} = T_{\\text{tot}} - x_2$, and $\\text{IRF3}_{\\text{u}} = I_{\\text{tot}} - x_3$.\n\nImpose the following kinetic assumptions to derive your ODEs:\n- STING activation is modeled as reversible binding of a constant ligand $L$ to free STING by mass action: $S_{\\text{free}} + L \\rightleftharpoons \\text{STING}^\\ast$ with forward rate constant $k_{1,\\text{on}}$ (in nM$^{-1}$ h$^{-1}$) and reverse rate constant $k_{1,\\text{off}}$ (in h$^{-1}$).\n- TBK1 activation is modeled as reversible binding or recruitment by active STING by mass action: $T_{\\text{free}} + \\text{STING}^\\ast \\rightleftharpoons \\text{TBK1}^\\ast$ with forward rate constant $k_{2,\\text{on}}$ (in nM$^{-1}$ h$^{-1}$) and reverse rate constant $k_{2,\\text{off}}$ (in h$^{-1}$).\n- IRF3 phosphorylation is catalyzed by active TBK1 via Michaelis–Menten kinetics acting on unphosphorylated IRF3 with turnover $k_{3,\\text{cat}}$ (in h$^{-1}$) and Michaelis constant $K_m$ (in nM), while dephosphorylation is first order with rate $k_{3,\\text{deph}}$ (in h$^{-1}$).\n- IFNB1 mRNA production has a basal transcription rate $k_{\\text{tx,basal}}$ (in nM h$^{-1}$) plus an activated term that is a Hill function of $x_3$ with maximal rate $k_{\\text{tx,act}}$ (in nM h$^{-1}$), activation constant $K_{\\text{act}}$ (in nM), and Hill coefficient $n$ (dimensionless). mRNA is degraded with first-order rate $\\gamma_m$ (in h$^{-1}$).\n- IFN-β protein is translated with rate $k_{\\text{tl}}$ (in h$^{-1}$) from mRNA and degraded with first-order rate $\\gamma_p$ (in h$^{-1}$).\n\nInitial conditions at $t = 0$ are:\n- $x_1(0) = 0$ nM, $x_2(0) = 0$ nM, $x_3(0) = 0$ nM, $x_4(0) = 0$ nM, $x_5(0) = 0$ nM.\n\nDefault parameter values (use these unless overridden in a particular test case), with concentrations in nM and time in hours:\n- $S_{\\text{tot}} = 100$, $T_{\\text{tot}} = 50$, $I_{\\text{tot}} = 100$.\n- $k_{1,\\text{on}} = 1.0$, $k_{1,\\text{off}} = 0.1$.\n- $k_{2,\\text{on}} = 1.0$, $k_{2,\\text{off}} = 0.2$.\n- $k_{3,\\text{cat}} = 5.0$, $K_m = 10$, $k_{3,\\text{deph}} = 0.5$.\n- $k_{\\text{tx,basal}} = 0.01$, $k_{\\text{tx,act}} = 1.0$, $K_{\\text{act}} = 20$, $n = 2$.\n- $\\gamma_m = 0.5$, $k_{\\text{tl}} = 2.0$, $\\gamma_p = 0.1$.\n\nMathematical requirements:\n- Derive and implement the ODE system implied by the above principles and definitions.\n- Define the Hill activation function as $H(x_3) = \\dfrac{x_3^n}{K_{\\text{act}}^n + x_3^n}$.\n- Simulate the system until it reaches steady state, which you must operationally define as $\\max_i |\\mathrm{d}x_i/\\mathrm{d}t|  10^{-6}$ nM h$^{-1}$ after at least $1$ hour has elapsed. If this criterion is not met, integrate up to a maximum of $T_{\\max} = 200$ hours and use the final values as the approximation to steady state.\n\nUnits and reporting:\n- All concentrations must be in nM, time in hours, and rates in the units specified above. Your output must be the steady-state IFN-β protein concentration $x_5$ in nM for each test case, rounded to three decimal places.\n\nTest suite:\nFor each of the following test cases, run the simulation and report the steady-state $x_5$ value.\n- Test $1$ (happy path): $L = 50$.\n- Test $2$ (boundary: no stimulus): $L = 0$.\n- Test $3$ (saturation stimulus): $L = 500$.\n- Test $4$ (strong phosphatase, reduced signaling): $L = 100$, override $k_{3,\\text{deph}} = 5.0$.\n- Test $5$ (STING deficiency): $L = 100$, override $S_{\\text{tot}} = 0$.\n\nFinal output format:\n- Your program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets (e.g., \"[r1,r2,r3,r4,r5]\"), where each $r_j$ is the steady-state IFN-β concentration in nM for test $j$, rounded to three decimal places and expressed as a decimal number (no units in the printed list).", "solution": "The problem statement has been rigorously validated and is determined to be scientifically sound, internally consistent, and mathematically well-posed. We may therefore proceed with the derivation of the model.\n\nThe objective is to formulate a system of ordinary differential equations (ODEs) describing the dynamics of the STING signaling pathway, leading to the production of Interferon-Beta (IFN-β). The derivation will be based on the principles of mass action kinetics, enzyme kinetics, and the Central Dogma, as specified. The state variables are the concentrations of active STING ($x_1$), active TBK1 ($x_2$), phosphorylated IRF3 ($x_3$), IFNB1 mRNA ($x_4$), and IFN-β protein ($x_5$).\n\nWe derive the rate equation for each state variable, $\\frac{dx_i}{dt}$, by summing the rates of all reactions that produce it and subtracting the rates of all reactions that consume it.\n\n1.  **Rate equation for active STING, $x_1(t) = \\text{STING}^\\ast$**:\n    The activation of STING is modeled as a reversible binding reaction between free STING, $S_{\\text{free}}$, and a constant ligand stimulus, $L$:\n    $$S_{\\text{free}} + L \\underset{k_{1,\\text{off}}}{\\stackrel{k_{1,\\text{on}}}{\\rightleftharpoons}} \\text{STING}^\\ast$$\n    Applying the Law of Mass Action, the rate of production of $x_1$ is $k_{1,\\text{on}} [S_{\\text{free}}] [L]$. The rate of consumption (inactivation) is $k_{1,\\text{off}} [STING^\\ast]$. Using the conservation law $S_{\\text{free}} = S_{\\text{tot}} - x_1$, the net rate of change of $x_1$ is:\n    $$\\frac{dx_1}{dt} = k_{1,\\text{on}}(S_{\\text{tot}} - x_1)L - k_{1,\\text{off}}x_1$$\n\n2.  **Rate equation for active TBK1, $x_2(t) = \\text{TBK1}^\\ast$**:\n    The activation of TBK1 is stated to follow $T_{\\text{free}} + \\text{STING}^\\ast \\rightleftharpoons \\text{TBK1}^\\ast$. Given the conservation law $T_{\\text{free}} = T_{\\text{tot}} - x_2$ and the fact that STING is a kinase-recruiting scaffold (acting catalytically), the most consistent interpretation is that active STING ($x_1$) catalyzes the conversion of free TBK1 ($T_{\\text{free}}$) to its active form ($x_2$). The forward rate is proportional to the concentrations of both the substrate, $T_{\\text{free}}$, and the catalyst, $x_1$. The reverse reaction is the inactivation of $x_2$.\n    The rate of production of $x_2$ is $k_{2,\\text{on}} [T_{\\text{free}}] [STING^\\ast] = k_{2,\\text{on}}(T_{\\text{tot}} - x_2)x_1$.\n    The rate of consumption (inactivation) of $x_2$ is $k_{2,\\text{off}} [TBK1^\\ast] = k_{2,\\text{off}}x_2$.\n    The net rate of change of $x_2$ is:\n    $$\\frac{dx_2}{dt} = k_{2,\\text{on}}(T_{\\text{tot}} - x_2)x_1 - k_{2,\\text{off}}x_2$$\n\n3.  **Rate equation for phosphorylated IRF3, $x_3(t) = \\text{IRF3-P}$**:\n    Active TBK1 ($x_2$) acts as an enzyme to phosphorylate unphosphorylated IRF3, $\\text{IRF3}_{\\text{u}} = I_{\\text{tot}} - x_3$. This catalytic process is described by Michaelis-Menten kinetics. The maximal velocity, $V_{\\text{max}}$, is proportional to the enzyme concentration, $V_{\\text{max}} = k_{3,\\text{cat}}[TBK1^\\ast] = k_{3,\\text{cat}}x_2$.\n    The rate of production of $x_3$ (phosphorylation) is $k_{3,\\text{cat}}x_2 \\frac{[\\text{IRF3}_{\\text{u}}]}{K_m + [\\text{IRF3}_{\\text{u}}]} = k_{3,\\text{cat}}x_2 \\frac{I_{\\text{tot}} - x_3}{K_m + (I_{\\text{tot}} - x_3)}$.\n    The dephosphorylation of $x_3$ is a first-order process with rate constant $k_{3,\\text{deph}}$. The rate of consumption is $k_{3,\\text{deph}}x_3$.\n    The net rate of change of $x_3$ is:\n    $$\\frac{dx_3}{dt} = k_{3,\\text{cat}}x_2 \\frac{I_{\\text{tot}} - x_3}{K_m + I_{\\text{tot}} - x_3} - k_{3,\\text{deph}}x_3$$\n\n4.  **Rate equation for IFNB1 mRNA, $x_4(t)$**:\n    Transcription of the IFNB1 gene has two components: a basal rate and an activated rate dependent on phosphorylated IRF3 ($x_3$). The activated component is described by a Hill function.\n    The rate of production of $x_4$ is $k_{\\text{tx,basal}} + k_{\\text{tx,act}} H(x_3)$, where $H(x_3) = \\frac{x_3^n}{K_{\\text{act}}^n + x_3^n}$.\n    The degradation of mRNA is a first-order process with rate constant $\\gamma_m$. The rate of consumption is $\\gamma_m x_4$.\n    The net rate of change of $x_4$ is:\n    $$\\frac{dx_4}{dt} = k_{\\text{tx,basal}} + k_{\\text{tx,act}}\\frac{x_3^n}{K_{\\text{act}}^n + x_3^n} - \\gamma_m x_4$$\n\n5.  **Rate equation for IFN-β protein, $x_5(t)$**:\n    The IFN-β protein is synthesized via translation of its mRNA ($x_4$) and is subject to degradation.\n    The rate of production (translation) is proportional to the mRNA concentration, with rate constant $k_{\\text{tl}}$: $k_{\\text{tl}}x_4$.\n    The degradation of the protein is a first-order process with rate constant $\\gamma_p$. The rate of consumption is $\\gamma_p x_5$.\n    The net rate of change of $x_5$ is:\n    $$\\frac{dx_5}{dt} = k_{\\text{tl}}x_4 - \\gamma_p x_5$$\n\nThis completes the derivation of the five coupled, non-linear ODEs. The system is solved numerically starting from the initial conditions $x_i(0) = 0$ for $i \\in \\{1, 2, 3, 4, 5\\}$. We integrate the system until a steady state is reached, defined as $\\max_i |\\frac{dx_i}{dt}|  10^{-6}$ for $t  1$ hour, or until a maximum time of $T_{\\max}=200$ hours. The final value of $x_5$ is reported.", "answer": "```python\n# The complete and runnable Python 3 code goes here.\n# Imports must adhere to the specified execution environment.\nimport numpy as np\nfrom scipy.integrate import solve_ivp\n\ndef solve():\n    \"\"\"\n    Main function to run simulations for all test cases and print results.\n    \"\"\"\n\n    # --- Default Parameter Definition ---\n    default_params = {\n        # Total concentrations (nM)\n        \"S_tot\": 100.0, \"T_tot\": 50.0, \"I_tot\": 100.0,\n        # STING activation (k1_on: nM^-1 h^-1, k1_off: h^-1)\n        \"k1_on\": 1.0, \"k1_off\": 0.1,\n        # TBK1 activation (k2_on: nM^-1 h^-1, k2_off: h^-1)\n        \"k2_on\": 1.0, \"k2_off\": 0.2,\n        # IRF3 phosphorylation (k3_cat: h^-1, Km: nM, k3_deph: h^-1)\n        \"k3_cat\": 5.0, \"Km\": 10.0, \"k3_deph\": 0.5,\n        # mRNA transcription (k_tx_basal: nM h^-1, k_tx_act: nM h^-1, K_act: nM, n: dimensionless)\n        \"k_tx_basal\": 0.01, \"k_tx_act\": 1.0, \"K_act\": 20.0, \"n\": 2.0,\n        # mRNA and protein dynamics (gamma_m, k_tl, gamma_p: h^-1)\n        \"gamma_m\": 0.5, \"k_tl\": 2.0, \"gamma_p\": 0.1,\n    }\n\n    # --- Test Case Definitions ---\n    # Each dictionary contains the stimulus L and any parameter overrides.\n    test_cases = [\n        {\"L\": 50.0},                                    # Test 1: Happy path\n        {\"L\": 0.0},                                     # Test 2: No stimulus\n        {\"L\": 500.0},                                   # Test 3: Saturation stimulus\n        {\"L\": 100.0, \"k3_deph\": 5.0},                    # Test 4: Strong phosphatase\n        {\"L\": 100.0, \"S_tot\": 0.0},                     # Test 5: STING deficiency\n    ]\n\n    results = []\n    for case_params in test_cases:\n        params = default_params.copy()\n        params.update(case_params)\n        \n        # --- ODE System Definition ---\n        def ode_system(t, x, p):\n            x1, x2, x3, x4, x5 = x\n            \n            # STING activation\n            # dx1/dt = k1_on * (S_tot - x1) * L - k1_off * x1\n            dx1dt = p[\"k1_on\"] * (p[\"S_tot\"] - x1) * p[\"L\"] - p[\"k1_off\"] * x1\n\n            # TBK1 activation (catalyzed by STING*)\n            # dx2/dt = k2_on * (T_tot - x2) * x1 - k2_off * x2\n            dx2dt = p[\"k2_on\"] * (p[\"T_tot\"] - x2) * x1 - p[\"k2_off\"] * x2\n\n            # IRF3 phosphorylation (catalyzed by TBK1*)\n            # dx3/dt = k3_cat * x2 * (I_tot - x3) / (Km + I_tot - x3) - k3_deph * x3\n            irf3u = p[\"I_tot\"] - x3\n            # Prevent division by zero, though unlikely with given params\n            denom_mm = p[\"Km\"] + irf3u\n            phos_rate = p[\"k3_cat\"] * x2 * irf3u / denom_mm if denom_mm > 0 else 0\n            dx3dt = phos_rate - p[\"k3_deph\"] * x3\n            \n            # IFNB1 mRNA transcription (activated by IRF3-P)\n            # dx4/dt = k_tx_basal + k_tx_act * x3^n / (K_act^n + x3^n) - gamma_m * x4\n            hill_term = (x3**p[\"n\"]) / (p[\"K_act\"]**p[\"n\"] + x3**p[\"n\"])\n            dx4dt = p[\"k_tx_basal\"] + p[\"k_tx_act\"] * hill_term - p[\"gamma_m\"] * x4\n\n            # IFN-beta protein translation\n            # dx5/dt = k_tl * x4 - gamma_p * x5\n            dx5dt = p[\"k_tl\"] * x4 - p[\"gamma_p\"] * x5\n            \n            return [dx1dt, dx2dt, dx3dt, dx4dt, dx5dt]\n\n        # --- Steady-State Event Definition ---\n        def steady_state_event(t, y, p):\n            if t  1.0:\n                return 1.0  # Do not trigger before t=1 hour\n            dydt = np.array(ode_system(t, y, p))\n            max_rate = np.max(np.abs(dydt))\n            return max_rate - 1e-6\n        \n        steady_state_event.terminal = True\n        steady_state_event.direction = -1 # Event occurs when value goes from positive to negative\n\n        # --- Numerical Integration ---\n        x0 = [0.0, 0.0, 0.0, 0.0, 0.0]\n        t_max = 200.0\n        t_span = (0, t_max)\n        \n        sol = solve_ivp(\n            ode_system, \n            t_span, \n            x0, \n            method='Radau', \n            args=(params,),\n            events=steady_state_event,\n            dense_output=True\n        )\n\n        # --- Result Extraction ---\n        # If integration stopped by event, use the event time state.\n        # Otherwise, use the state at t_max.\n        if sol.status == 1 and sol.t_events[0].size > 0:\n            steady_state_x = sol.y_events[0][0]\n        else:\n            steady_state_x = sol.y[:, -1]\n        \n        # IFN-beta is the 5th variable (index 4)\n        result_x5 = steady_state_x[4]\n        results.append(result_x5)\n\n    # --- Final Output Formatting ---\n    formatted_results = [f\"{r:.3f}\" for r in results]\n    print(f\"[{','.join(formatted_results)}]\")\n\nsolve()\n```", "id": "2879710"}]}